Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 6, 2010, Pages 555.e1-555.e10

  Pereira, Leonardo ^a   Reddy, Ashok P ^b   Alexander, Amanda L ^a   Lu, Xinfang ^c   Lapidus, Jodi A ^a,c   Gravett, Michael G ^d   Nagalla, Srinivasa R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Diabetomics LLC   (United States)

^c Proteogenix Inc   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

glycoprotein; peptide; preterm birth; preterm labor; proteomics

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEOME; PROTEOME; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CLASSIFIER; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; FETUS DEVELOPMENT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA DEVELOPMENT; PREMATURE LABOR; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 77952741206     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.02.048     Document Type: Article

References (39)

1. Martin J., Hamilton B., Sutton P., Ventura S., Menacker F., and Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep 55 (2006) 1-101
2. Copper R.L., Goldenberg R.L., Creasy R.K., et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 169 (1993) 352-366
3. Meis P.J., Klebanoff M., Thom E., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
4. da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
5. Simmer K., Lort-Phillips L., James C., and Thompson R.P.H. A double-blind trial of zinc supplementation in pregnancy. Eur J Clin Nutr 45 (1991) 139-144
6. To M.S., Skentou C.A., Royston P., Yu C.K., and Nicolaides K.H. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 27 (2006) 362-367
7. Berghella V., Odibo A.O., To M.S., Rust O.A., and Althuisius S.M. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 106 (2005) 181-189
8. Slattery M.M., and Morrison J.J. Preterm delivery. Lancet 360 (2002) 1489-1497
9. Morken N.H., Vogel I., Kallen K., et al. Reference population for international comparisons and time trend surveillance of preterm delivery proportions in three countries. BMC Women's Health 8 (2008) 16
10. Crider K.S., Whitehead N., and Buus R.M. Genetic variation associated with preterm birth: a huge review. Genet Med 7 (2005) 593-604
11. Sagiv S.K., Mendola P., Loomis D., et al. A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001. Environ Health Perspect 113 (2005) 602-606
12. Vogel I., Thorsen P., Curry A., Sandager P., and Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 84 (2005) 516-525
13. Iams J.D., Goldenberg R.L., Mercer B.M., et al. The Preterm Prediction study: recurrence risk of spontaneous preterm birth. Am J Obstet Gynecol 178 (1998) 35-40
14. Dugoff L., Hobbins J.C., Malone F.D., et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106 (2005) 260-267
15. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl L Med 327 (1992) 308-312
16. Cox S.M., Sherman M.L., and Leveno K.J. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol 163 (1992) 767-772
17. Buhimschi C.S., Weiner C.P., and Buhimschi I.A. Clinical proteomics: a novel diagnostic tool for the new biology of preterm labor: part I, proteomics tools. Obstet Gynecol Surv 61 (2006) 481-486
18. Pereira L., Reddy A.P., Jacob T., et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 6 (2007) 1269-1276
19. Nagalla S.R., Canick J.A., Jacob T., et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J Proteome Res 6; (2007) 1245-1257
20. Gravett M.G., Thomas A., Schneider K.A., et al. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 6 (2007) 89-96
21. Gravett M.G., Novy M.J., Rosenfeld R.G., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292 (2004) 462-469
22. Old W.M., Meyer-Arendt K., Aveline-Wolf L., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 4 (2005) 1487-1502
23. Zybailov B., Coleman M.K., Florens L., and Washburn M.P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem 77 (2005) 6218-6224
24. Zybailov B., Mosley A.L., Sardiu M.E., Coleman M.K., Florens L., and Washburn M.P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 5 (2006) 2339-2347
25. Moawad A.H., Goldenberg R.L., Mercer B., et al. The Preterm Prediction study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol 186 (2002) 990-996
26. Menon R., Fortunato S.J., Thorsen P., and Williams S. Genetic associations in preterm birth: a primer of marker selection, study design, and data analysis. J Soc Gynecol Investig 13 (2006) 531-541
27. Astolfi P., De Pasquale A., and Zonta L. Late childbearing and its impact on adverse pregnancy outcome: stillbirth, preterm delivery and low birth weight. Rev Epidemiol Sante Publique 53 suppl 2 (2005) 2S97-105
28. Heine R.P., McGregor J.A., Goodwin T.M., et al. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol 96 (2000) 490-497
29. Revah A., Hannah M.E., and Sue-A-Quan A.K. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol 15 (1998) 613-621
30. Surbek D., Bosiger H., Pavic N., Huber P., Almendral A.C., and Holzgreve W. [Fetal fibronectin as a marker of prematurity in a high risk patient sample]. Z Geburtshilfe Neonatol 201 (1997) 15-20
31. Iams J.D., Goldenberg R.L., Meis P.J., et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 334 (1996) 567-572
32. Lockwood C.J., and Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 15 suppl (2001) 78-89
33. Wang X., Zuckerman B., Kaufman G., et al. Molecular epidemiology of preterm delivery: methodology and challenges. Paediatr Perinat Epidemiol 15 suppl (2001) 63-77
34. Roman A.S., Rebarber A., Pereira L., Sfakianaki A.K., Mulholland J., and Berghella V. The efficacy of sonographically indicated cerclage in multiple gestations. J Ultrasound Med 24 (2005) 763-768
35. Rouse D.J., Caritis S.N., Peaceman A.M., et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: a trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
36. Papatsonis D.N., Van Geijn H.P., Ader H.J., Lange F.M., Bleker O.P., and Dekker G.A. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 90 (1997) 230-234
37. Romero R., Sibai B.M., Sanchez-Ramos L., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 182 (2000) 1173-1183
38. Goldenberg R.L., and Rouse D.J. Prevention of premature birth. N Engl J Med 339 (1998) 313-320
39. Simhan H.N., and Caritis S.N. Prevention of preterm delivery. N Engl J Med 357 (2007) 477-487